Watson CEO Must Face FTC Subpoena: Judge

Law360, New York (August 17, 2010, 7:30 PM EDT) -- The CEO of Watson Pharmaceuticals Inc. should be forced to testify in a Federal Trade Commission investigation into whether the drugmaker entered a pay-for-delay deal with Cephalon Inc., a magistrate judge has ruled.

Though the FTC's investigative methods are “questionable,” the commission serving a subpoena on Watson CEO Paul M. Bisaro is not abusive, Magistrate Judge Alan Kay said Tuesday in a report issued in the U.S. District Court for the District of Columbia.

“The fact that Mr. Bisaro is the CEO and president of Watson...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.